We have managed to restructure CEDEM AG and to expand its operations in Germany, Switzerland, Jordan and the UK, as well as in other markets. As a Jordanian living abroad, Ms. Oudeh is deeply committed to share her insights, expertise and knowledge with fellow Jordanians, and to keep engaged in Jordan’s economy. This objective is also consistent with donor organizations’ strategies.
“It has been a long journey up along the road, from a limited salary to an entrepreneur in the pharmaceutical industry with an annual turnover of millions of dollars, and from being a governmental employee to an owner, shareholder and director of several Jordanian, Swiss and German companies with more than 30 regional and international traders and business partners around the globe” Rasha Oudeh/ CEO
CEDEM has its own regional office in Jordan, which is well staffed with qualified human resources and facilities to follow up CEDEM’s operations in Jordan and the rest of the MENA region. Most of Cedem’s employees are females and they graduate of the Jordanian German University.
1- Dead Sea Parcel :
CEDEM has launched this line of Dead Sea products in order to be part of Jordan’s efforts to combat poverty, unemployment and refugees problems. our vision is to establish itself as a leading example in brand labeling healthcare products from and to the Middle East countries
People in Jordan have a long history and an accumulation of traditions in manufacturing Dead Sea products. It is a vital source of making a living for hard working people, especially underprivileged women.
2- Training for Employment:
CEDEM has launched its own program of “training for employment”, such as start-up workshops, international trading cycle and supply chain management, whereby trainees will have job opportunities either with CEDEM or with other European, Arab and Jordanian companies. The program comes in 2 parts:
- Startups & Entrepreneurs workshops and training sessions
- The concepts and approaches (business models) of the private labeling industry.
3- Precision Medicine Initiative :
CEDEM AG Germany is the sole representative of the FIZ Frankfurt Biotechnology Innovation Center in the MENA region. The focus of FiZ synergy projects is placed on precision medicine and disruptive business models in the healthcare sector.
Precision medicine describes how genetic information is used to characterize a person’s disease, and provide doctors with more accurate diagnosis and treatment options; This in turn gives patients a higher rate of survival. Cancer is a disease of the genome, and as more is learned about cancer tumors, the more we can find that each tumor has its own set of genetic changes. Understanding the genetic changes in cancer cells is leading to more effective treatment strategies that are tailored to the genetic profile of each patient’s cancer.
For more information on the OptiCancer project and Precision Medicine, visit our website www.opticancer.net or our videos :